Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

KRX/118000 stock hub

KRX/118000 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/118000is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.7B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/118000

In the news

Latest news · KRX/118000

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E69.3

P25 12P50 23.1P75 39.5

ROE-0.2

P25 -17.1P50 0.7P75 8.5

ROIC0.7

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/118000 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

KRW

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	31
Enterprise value	KRW 94.8B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	KR7118000009
Last refreshed	2026-05-10
Market cap	KRW 35.7B
Price	KRW 2,080
Price currency	KRW
Rev Per Employee	1,058,776,490.32x
Sector	Healthcare
Sic	3841
Symbol	krx/118000
Website	https://www.meta-care.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.39%
EV Earnings	190.25x
EV/EBIT	71.55x
EV/EBITDA	20.48x
EV/FCF	-4.16x
EV/Sales	2.89x
FCF yield	-63.78%
P/B ratio	0.3x
P/E ratio	69.33x
P/S ratio	1.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.04%
EBITDA Margin	14.1%
Gross margin	30.37%
Gross Profit	KRW 10B
Gross Profit Growth	30.4%
Gross Profit Growth Q	10.11%
Gross Profit Growth3 Y	15.4%
Gross Profit Growth5 Y	55.67%
Net Income	KRW 498.2M
Net Income Growth	-94.14%
Net Income Growth Years	0%
Net Income Growth5 Y	-46.39%
Pretax Margin	-0.62%
Profit Margin	1.52%
Profit Per Employee	KRW 16.1M
Profitable Years	2
ROA	0.47
Roa5y	0.13
ROCE	0.9
ROE	-0.18
Roe5y	-6.36
ROIC	0.74
Roic5y	0.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-25.5%
Cagr15y	-17.01%
Cagr1y	-37.37%
Cagr3y	-31.1%
Cagr5y	-36.45%
EPS Growth	-94.74
EPS Growth Years	0
EPS Growth5 Y	-59.11
OCF Growth	-45.95%
OCF Growth Q	-89.37%
OCF Growth5 Y	-8.61%
Revenue Growth	62.42x
Revenue Growth Q	84.33x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	19.78x
Revenue Growth5 Y	37.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.18
Assets	KRW 198B
Cash	KRW 1.8B
Current Assets	KRW 17.5B
Current Liabilities	KRW 51.6B
Debt	KRW 59.3B
Debt EBITDA	KRW 12.82
Debt Equity	KRW 0.49
Debt FCF	KRW -2.6
Equity	KRW 121B
Interest Coverage	0.54
Liabilities	KRW 77B
Long Term Assets	KRW 180.4B
Long Term Liabilities	KRW 25.4B
Net Cash	KRW -57.5B
Net Cash By Market Cap	KRW -161
Net Debt EBITDA	KRW 12.42
Net Debt Equity	KRW 0.48
Tangible Book Value	KRW 99.4B
Tangible Book Value Per Share	KRW 6,127
WACC	5.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.34
Inventory Turnover	22.91
Net Working Capital	KRW 433.9M
Quick ratio	0.28
Working Capital	KRW -34B
Working Capital Turnover	KRW 14.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.73%
1Y total return	-37.35%
200-day SMA	3,026.5
3Y total return	-67.3%
50-day SMA	2,603.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.63%
All Time High	438,000
All Time High Change	-99.53%
All Time High Date	2012-02-20
All Time Low	2,030
All Time Low Change	2.46%
All Time Low Date	2026-04-23
ATR	146.3
Beta	0.73
Beta1y	0.61
Beta2y	0.24
Ch YTD	-31.8
High	2,250
High52	4,130
High52 Date	2025-06-16
High52ch	-49.64%
Low	2,030
Low52	2,030
Low52 Date	2026-04-23
Low52ch	2.46%
Ma50ch	-20.1%
Price vs 200-day SMA	-31.27%
RSI	30.44
RSI Monthly	31.15
RSI Weekly	30.16
Sharpe ratio	-0.8x
Sortino ratio	-1.03
Total Return	-11.42%
Tr YTD	-31.8
Tr15y	-93.89%
Tr1m	-15.1%
Tr1w	-7.96%
Tr3m	-28.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 1.3B
Operating Income Growth	-11.97
Operating margin	4.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,915,196%
Net Borrowing	25,637,761,460
Shares Out	17,177,521
Shares Qo Q	-6.02%
Shares Yo Y	11.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -22.8B
Average Volume	140,374.4x
Bv Per Share	7,364.9
CAPEX	KRW -25.2B
Ch10y	-95.33
Ch15y	-95.42
Ch1m	-15.1
Ch1w	-7.96
Ch1y	-37.35
Ch3m	-28.77
Ch3y	-67.3
Ch5y	-90.8
Ch6m	-32.03
Change	-6.31%
Change From Open	-5.88
Close	2,220
Days Gap	-0.45
Depreciation Amortization	3,303,268,000
Dollar Volume	616,335,200
Earnings Date	2026-05-15
EBIT	KRW 1.3B
EBITDA	KRW 4.6B
EPS	KRW 30
F Score	6
FCF	KRW -22.8B
FCF EV Yield	-24.04x
FCF Per Share	KRW -1,327
Financing CF	28,842,496,950
Fiscal Year End	December
Founded	2,009
Goodwill	7,496,562,000
Graham Number	2229.64065
Graham Upside	7.19
Income Tax	KRW 7M
Investing CF	-59,729,395,150
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2014-02-13
Last Split Type	Reverse
Lynch Fair Value	KRW 150
Lynch Upside	-92.79
Ma150	2,942.6
Ma150ch	-29.31%
Ma20	2,275.5
Ma20ch	-8.59%
Net CF	-28,467,192,080
Next Earnings Date	2026-05-15
Open	2,210
P OCF Ratio	14.77
Position In Range	22.73
Ppne	4,273,066,110
Price Date	2026-04-23
Price EBITDA	KRW 7.72
Ptbv Ratio	0.36
Relative Volume	2.11x
Revenue	32,822,071,200x
SBC By Revenue	0.05x
Share Based Comp	17,112,000
Tax By Revenue	0.02x
Tr6m	-32.03%
Volume	296,315
Z Score	-0.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/118000 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/118000 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/118000?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.4%

Negative means the company is buying back shares.

Technical

KRX/118000 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.4

Neutral momentum band

Price vs 200-day MA

-31.3%

50/200-day relationship not available

Beta (5Y)

0.73

Less volatile than the market

Sharpe ratio

-0.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/118000

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/118000 stock rating?

krx/118000 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/118000 analysis?

The full report lives at /stocks/krx/118000/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/118000?

The latest report frames krx/118000 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/118000 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.